{
    "Trade/Device Name(s)": [
        "Glucophone\u2122 Blood Glucose Monitoring System",
        "Glucophone\u2122M Blood Glucose Testing System"
    ],
    "Submitter Information": "Infopia Co., Ltd.",
    "510(k) Number": "K091168",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052469",
        "K051285"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "May 21, 2010",
    "Summary Letter Received Date": "May 24, 2010",
    "Submission Date": "May 21, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Glucophone\u2122M Meter combined with Cell Phone (Motorola v3)"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase enzymatic reaction",
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Electrochemical signal generation"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Glucophone\u2122 Blood Glucose Monitoring System utilizing glucose oxidase and electrochemical detection integrated with a cell phone.",
    "Indications for Use Summary": "Quantitative measurement of glucose in capillary whole blood from various sites for diabetic patients or healthcare professionals in home and clinical settings; for in vitro use only; compatible with cell phone; not for neonatal use or diabetes diagnosis/screening; alternate site testing during steady state.",
    "fda_folder": "Clinical Chemistry"
}